|
|
| | 1H-Pyrazole-4-carboxamide, 5-amino-N-[2-[[(2,6-dichlorobenzoyl)ethylamino]methyl]-3,3,3-trifluoro-2-hydroxypropyl]-1-(4-fluorophenyl)- Basic information |
| | 1H-Pyrazole-4-carboxamide, 5-amino-N-[2-[[(2,6-dichlorobenzoyl)ethylamino]methyl]-3,3,3-trifluoro-2-hydroxypropyl]-1-(4-fluorophenyl)- Chemical Properties |
| Boiling point | 761.3±60.0 °C(Predicted) | | density | 1.49±0.1 g/cm3(Predicted) | | pka | 9.13±0.46(Predicted) |
| | 1H-Pyrazole-4-carboxamide, 5-amino-N-[2-[[(2,6-dichlorobenzoyl)ethylamino]methyl]-3,3,3-trifluoro-2-hydroxypropyl]-1-(4-fluorophenyl)- Usage And Synthesis |
| Description | GSK866 is a selective glucocorticoid receptor agonist (SEGRA). |
| | 1H-Pyrazole-4-carboxamide, 5-amino-N-[2-[[(2,6-dichlorobenzoyl)ethylamino]methyl]-3,3,3-trifluoro-2-hydroxypropyl]-1-(4-fluorophenyl)- Preparation Products And Raw materials |
|